首页> 美国卫生研究院文献>Children >Multimodal Treatment of Pediatric Ruptured Brain Arteriovenous Malformations: A Single-Center Study
【2h】

Multimodal Treatment of Pediatric Ruptured Brain Arteriovenous Malformations: A Single-Center Study

机译:儿科脑动脉畸形畸形的多峰治疗:单中心研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bleeding from ruptured brain arteriovenous malformations (bAVMs) represents the most prevalent cause of pediatric intracranial hemorrhage, being also the most common initial bAVM manifestation. A therapeutic approach in these patients should aim at preventing rebleeding and associated significant morbidity and mortality. The purpose of this study was to determine the clinical outcomes of pediatric patients who initially presented at our institution with ruptured bAVMs and to review our experience with a multimodality approach in the management of pediatric ruptured bAVMs. We retrospectively reviewed pediatric patients’ medical records with ruptured bAVMs who underwent interventional treatment (microsurgery, embolization, or radiosurgery; solely or in combination) at our institution between 2011 and 2020. We identified 22 patients. There was no intraoperative and postoperative intervention-related mortality. Neither procedure-related complications nor rebleeding were observed after interventional treatment. Modified Rankin Scale (mRS) assessment at discharge revealed 19 patients (86.4%) with favorable outcomes (mRS 0–2) and 3 patients (13.6%) classified as disabled (mRS 3). Microsurgery ensured the complete obliteration in all patients whose postoperative digital subtraction angiography (DSA) was available. Management of high-grade bAVMs with radiosurgery or embolization can provide satisfactory outcomes without a high disability risk.
机译:来自破裂的脑动脉畸形(BAMM)出血代表了儿科颅内出血的最普遍原因,也是最常见的初始BAVM表现形式。这些患者的治疗方法应旨在预防再交性和相关的显着发病率和死亡率。本研究的目的是确定初始在我们的机构介绍的儿科患者的临床结果,并审查我们在儿科破裂巴伐利受管制中的多模态方法的经验。我们回顾性地审查了儿科患者的医疗记录,患有介入治疗(显微外科,栓塞或放射牢房;在2011年和2020年之间的机构进行了介入治疗(显微外科,栓塞或放射外科)。我们确定了22名患者。没有术语和术后干预相关的死亡率。在介入治疗后,既不会观察到与过程相关的并发症也不观察到。在出院时改进的Rankin规模(MRS)评估显示,19名患者(86.4%),归类于禁用(3岁)和3名患者(3.6%)(3岁)。显微外科确保所有术后减法血管造影(DSA)的患者完全抹掉。具有放射外科或栓塞的高级BAMM的管理可以提供令人满意的结果,没有高的残疾风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号